Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria

J Infect. 2018 Nov;77(5):448-454. doi: 10.1016/j.jinf.2018.07.013. Epub 2018 Jul 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bacterial Proteins
  • Fosfomycin*
  • Humans
  • Klebsiella pneumoniae
  • Liver Diseases*
  • beta-Lactamases

Substances

  • Bacterial Proteins
  • Fosfomycin
  • beta-Lactamases
  • carbapenemase